XM does not provide services to residents of the United States of America.

Colombia's central bank board seen making 50 bp cut at last 2024 meeting



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Colombia's central bank board seen making 50 bp cut at last 2024 meeting</title></head><body>

By Nelson Bocanegra

BOGOTA, Dec 20 (Reuters) -The board of Colombia's central bank will meet on Friday for its last meeting of the year, where analysts expect members to vote to cut the benchmark interest rate by 50 basis points amid global uncertainty and the country's fiscal challenges.

All 25 analysts in a recent Reuters poll said they expect the board to vote for a cut of 50 basis points, taking the benchmark interest rate to 9.25%.

If the analysts' forecast is right, the cut would be the seventh consecutive 50 basis point-reduction.

"Prudence must be maintained" because of uncertainty about the course of the Fed, a coming minimum wage increase in Colombia for 2025 and fiscal uncertainty in the Andean country, said Wilson Tovar, chief economist of brokerage Acciones y Valores.

The government of President Gustavo Petro has been afflicted with fiscal troubles, which have put at risk compliance with the country's so-called fiscal rule, designed to impose limits on spending to prevent deterioration of public finances.

This month Congress rejected a $2.7 billionfiscal reform proposed by the government to finance 2025 spending.

On Thursday, Colombia's Autonomous Fiscal Rule Committee said the Andean country would need to cut spending this year by 40 trillion pesos, followed by a subsequent cut of 52 trillion pesos next year.

Colombia's 12-month inflation through the end of November closed at 5.20%, above the bank's 3% target.

"Although inflation has corrected, it remains outside the target range and the central bank wants to ensure convergence in 2025, so it must continue to have a restrictive rate," said Laura Pirajan, chief economist of Scotiabank in Colombia.

The bank has cut its benchmark rate by 325 basis points since launching a downward monetary policy in December last year.



Reporting by Nelson Bocanegra
Writing by Oliver Griffin; Editing by Alistair Bell

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.